Natures Sunshine Products Inc

Ownership Transactions Reported by 25 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	0
Sells	3	-22.1K	100%	$16.91	-$373K
Net	-3	-22.1K	-100%		-$373K

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.	10%+ Owner	$51.8M			Apr 12, 2021
Wynnefield Partners Small Cap Value Lp	10%+ Owner	$50.7M			Sep 15, 2022
Willem Mesdag	10%+ Owner	$9.29M			Sep 15, 2021
Terrence Moorehead	Chief Executive Officer, Director	$7.92M			Jul 21, 2024
Joseph W. Baty	EVP & Chief Financial Officer	$3.07M			Jul 21, 2022
Leslie Shane Jones	EVP & Chief Financial Officer	$1.91M			Apr 20, 2024
Bryant J. Yates	EVP & President, Europe	$1.51M	-$46.9K	-3.01%	Jul 21, 2024
Christopher Teets	Director	$1.06M			May 6, 2024
Daniel C. Norman	EVP & President, Asia	$976K	-$257K	-20.8%	Jul 21, 2024
Edward Silcock	EVP & President, North America	$911K			Jul 21, 2022
Tracee Comstock	VP, Human Resources	$896K			Jul 21, 2024
Martin A. Gonzalez	EVP, Global Supply Chain	$884K			Jul 21, 2024
Mary B. Springer	Director	$856K			May 4, 2022
Robert D. Straus	Director	$841K			May 6, 2024
Jonathan D. Lanoy	SVP, Chief Accounting Officer	$777K			Jul 21, 2024
Nathan Brower	EVP, General Counsel	$759K	-$69.2K	-8.36%	Jul 21, 2024
Richard D. Moss	Director	$738K			May 6, 2024
Heidi Wissmiller	Director	$557K			May 6, 2024
Kevin R. Herbert	EVP & President, North America	$478K			Jun 26, 2024
Sarah Crockett	Global Chief Marketing Officer	$476K			Mar 11, 2024
Rong Yang	Director	$425K			May 6, 2024
Tess Roering	Director	$419K			May 6, 2024
Curtis Kopf	Director	$419K			May 6, 2024
Shirley Wu	Director	$162K			May 4, 2022
Tariq Hassan	Director	$55.2K			Jul 1, 2021

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.